Polymorphic forms of a macrocyclic inhibitor of HCV

Details for Australian Patent Application No. 2008209696 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Swinney, Kelly Ann; Stokbroekx, Sigrid Carl Maria; Wuyts, Stijn; Leys, Carina; Horvath, Andras

Agent Shelston IP

Pub. Number AU-A-2008209696

PCT Pub. Number WO2008/092954

Priority 07101563.0 01.02.07 EP

Filing date 1 February 2008

Wipo publication date 7 August 2008

International Classifications

A61K 31/465 (2006.01) - Nicotine

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/092954 Priority application(s): WO2008/092954

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209697-Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

2008209677-Plants having enhanced yield-related traits and/or increased abiotic stress resistance, and a method for making the same